MT1G was previously reported to inhibit ferroptosis by blocking glutathione depletion-mediated lipid peroxidation in hepatocellular carcinoma cells and clear cell renal cell carcinoma, and to promote sorafenib resistance in hepatocellular carcinoma cells. Here, MT1G is linked to hepatocellular carcinoma.